Old Web
English
Sign In
Acemap
>
Paper
>
Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
2018
Niluja Thiruthaneeswaran
B. Bibby
Lingjian Yang
Darragh McArt
Ananya Choudhury
Catharine M L West
Keywords:
Repurposing
Pathology
Prostate cancer
Pharmacology
Medicine
Oncology
Medical physics
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]